Novo Nordisk A/S Common Stock (NVO)

Cash & Short-Term Investments

kr 44.98B

Quarterly · Period ending: · DKK

NVO logo

NVO Cash & Short-Term Investments

Latest reportedkr 44.98B DKK
NVO Quarterly Cash & Short-Term Investments · DKK (kr 2.11B → kr 44.98B)
High-resolution chart · PNG

NVO cash & short-term investments history

Quarterly · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock Cash & Short-Term Investments — Quarterly (DKK)
Period endingCash & Short-Term Investments (DKK)
44,982,000,000
21,626,000,000
26,962,000,000
32,583,000,000
18,934,000,000
41,550,000,000
26,308,000,000
74,881,000,000
9,004,340,202
9,303,000,000
30,230,000,000
6,757,581,781
5,334,622,738
4,050,287,681
23,574,000,000
4,937,219,199
4,363,204,397
3,013,454,792
17,485,000,000
5,515,811,785
4,340,289,129
1,211,450,785
2,096,983,644
4,014,020,716
3,748,370,617
1,435,860,487
2,324,620,700
18,757,000,000
14,457,000,000
9,055,000,000
15,638,000,000
16,401,000,000
18,393,000,000
10,513,000,000
18,852,000,000
19,137,000,000
21,330,000,000
17,766,000,000
20,699,000,000
16,579,000,000
15,220,000,000
8,850,000,000
20,465,000,000
17,508,000,000
11,839,000,000
7,188,000,000
15,905,000,000
13,620,000,000
6,523,000,000
5,168,000,000
14,469,000,000
13,482,000,000
11,123,000,000
11,223,000,000
16,105,000,000
17,545,000,000
12,390,000,000
13,303,000,000
17,502,000,000
17,905,000,000
16,493,000,000
14,601,000,000
16,051,000,000
12,989,000,000
11,982,000,000
10,175,000,000
12,826,000,000
11,863,000,000
9,954,000,000
9,313,000,000
10,184,876,800
8,790,281,000
8,772,444,300
7,384,347,800
7,384,616,000
6,037,903,600
5,555,858,500
4,827,547,700
5,102,491,800
5,023,236,540
4,839,370,400
4,389,334,950
5,017,968,080
4,019,608,800
2,972,599,350
2,850,665,760
3,989,637,870
3,470,946,200
2,540,985,330
2,320,124,160
3,098,254,800
1,741,111,740
3,049,213,650
1,275,370,800
1,973,933,670
798,675,108
1,122,911,280
1,572,002,159
2,999,884,600
6,684,733,370
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.